• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[可穿戴式心脏复律除颤器(WCD)]

[The Wearable Cardioverter-Defibrillator (WCD)].

作者信息

Helms Thomas M, Müller A, Schwab J O, Bänsch D, Karle C, Klingenheben T, Zugck C, Perings C

机构信息

Deutsche Stiftung für chronisch Kranke, Alexanderstraße 26, 90762, Fürth, Deutschland,

出版信息

Herzschrittmacherther Elektrophysiol. 2015 Jun;26(2):129-33. doi: 10.1007/s00399-015-0365-7. Epub 2015 May 5.

DOI:10.1007/s00399-015-0365-7
PMID:25939989
Abstract

While the implantable cardioverter-defibrillator (ICD) has been proven to be the best choice for patients with long-term risk for sudden cardiac arrest/sudden cardiac death (SCA/SCD), the question is how to manage patients with only temporary risk, e.g., during the guidelines-recommended waiting period until the decision for an ICD can be made. These patient groups should be monitored around the clock to guarantee a lifesaving shock within a few minutes, if necessary.These conditions can be accomplished by the wearable cardioverter-defibrillator (WCD) in the outpatient sector. The WCD is worn on the skin and consists of four nonadhesive ECG electrodes as well as three defibrillation electrodes-two at the back and one at the front-embedded in a garment. The defibrillation unit is connected via a cord and can be worn over the shoulder or on a belt. Cardiac events can be recorded and retrospectively analyzed by the treating physician.The WCD is a safe and effective measure to terminate potentially lethal ventricular tachycardia and ventricular fibrillation. It may be used early after myocardial infarction with reduced left ventricular ejection fraction (LVEF), as well as for patients with acute heart failure in nonischemic cardiomyopathy with uncertain cause and prognosis. In addition, it may be used for patients waiting for heart transplantation, for patients who cannot be implanted an ICD due to comorbidities, and for patients after explantation of their ICD, e.g., because of infection until reimplantation.One may expect that risk stratification of patients with the WCD will lead to even better selection for ICD use.

摘要

虽然植入式心脏复律除颤器(ICD)已被证明是有心脏骤停/心源性猝死(SCA/SCD)长期风险患者的最佳选择,但问题是如何管理仅具有临时风险的患者,例如在指南推荐的等待期内,直到可以做出植入ICD的决定。这些患者群体应进行全天候监测,以确保在必要时能在几分钟内给予救命电击。在门诊环境中,可穿戴式心脏复律除颤器(WCD)可以满足这些条件。WCD穿戴在皮肤上,由四个非粘性心电图电极以及三个除颤电极组成,其中两个在背部,一个在前部,嵌入一件衣服中。除颤单元通过一根电线连接,可以挂在肩上或系在腰带上。治疗医生可以记录心脏事件并进行回顾性分析。WCD是终止潜在致命性室性心动过速和心室颤动的一种安全有效的措施。它可在心肌梗死后左心室射血分数(LVEF)降低的早期使用,也可用于病因和预后不明的非缺血性心肌病急性心力衰竭患者。此外,它还可用于等待心脏移植的患者、因合并症无法植入ICD的患者以及ICD取出后(例如因感染直到重新植入)的患者。人们可能期望对使用WCD的患者进行风险分层将导致ICD使用的选择更加优化。

相似文献

1
[The Wearable Cardioverter-Defibrillator (WCD)].[可穿戴式心脏复律除颤器(WCD)]
Herzschrittmacherther Elektrophysiol. 2015 Jun;26(2):129-33. doi: 10.1007/s00399-015-0365-7. Epub 2015 May 5.
2
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.植入式心脏复律除颤器治疗的风险分层:可穿戴式心脏除颤器的作用。
Eur Heart J. 2013 Aug;34(29):2230-42. doi: 10.1093/eurheartj/eht167. Epub 2013 May 31.
3
Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).可穿戴式心脏除颤器在高危心脏患者中的应用:来自前瞻性可穿戴式心脏除颤器(WEARIT-II 注册研究)患者使用登记数据库的数据。
Circulation. 2015 Oct 27;132(17):1613-9. doi: 10.1161/CIRCULATIONAHA.115.015677. Epub 2015 Aug 27.
4
Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.心力衰竭患者的治疗优化:可穿戴式心脏复律除颤器在实际应用中的作用。
BMC Cardiovasc Disord. 2018 Mar 15;18(1):52. doi: 10.1186/s12872-018-0790-8.
5
Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.使用可穿戴式心脏复律除颤器移除植入式心脏复律除颤器(ICD)后预防门诊患者心源性猝死
Pacing Clin Electrophysiol. 2014 May;37(5):562-8. doi: 10.1111/pace.12319. Epub 2013 Dec 3.
6
[The wearable cardioverter/defibrillator : Temporary protection from sudden cardiac death].[可穿戴式心脏复律除颤器:预防心源性猝死的临时保护措施]
Internist (Berl). 2016 Sep;57(9):864-70. doi: 10.1007/s00108-016-0110-2.
7
Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD.已植入式心律转复除颤器患者中可穿戴式除颤器的长期使用。
Int J Cardiol. 2018 Dec 1;272:179-184. doi: 10.1016/j.ijcard.2018.08.017. Epub 2018 Aug 10.
8
The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients.真实临床环境中的可穿戴式心脏复律除颤器:102例连续患者的经验
Clin Res Cardiol. 2017 Apr;106(4):300-306. doi: 10.1007/s00392-016-1054-1. Epub 2016 Nov 25.
9
Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD).降低心律失常性猝死的短期高风险。可穿戴式心脏复律除颤器(WCD)的应用经验。
Pacing Clin Electrophysiol. 2010 Mar;33(3):353-67. doi: 10.1111/j.1540-8159.2009.02590.x. Epub 2009 Nov 2.
10
Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.穿戴式心脏除颤器在心肌梗死后早期被认为高危患者中的应用。
J Am Coll Cardiol. 2013 Nov 19;62(21):2000-2007. doi: 10.1016/j.jacc.2013.05.086. Epub 2013 Jul 31.

引用本文的文献

1
Wearable Cardioverter-Defibrillator Used as a Telemonitoring System in a Real-Life Heart Failure Unit Setting.可穿戴式心脏复律除颤器在实际心力衰竭病房环境中用作远程监测系统。
J Clin Med. 2021 Nov 22;10(22):5435. doi: 10.3390/jcm10225435.
2
[Present and future relevance of telemedicine in cardiac arrhythmia emergencies].
Herzschrittmacherther Elektrophysiol. 2020 Mar;31(1):73-76. doi: 10.1007/s00399-020-00671-1. Epub 2020 Feb 4.

本文引用的文献

1
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2014年美国心脏协会/美国心脏病学会非ST段抬高型急性冠状动脉综合征患者管理指南:美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Dec 23;64(24):e139-e228. doi: 10.1016/j.jacc.2014.09.017. Epub 2014 Sep 23.
2
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias.欧洲心律协会/美国心律学会/亚太心律学会关于室性心律失常的专家共识
Heart Rhythm. 2014 Oct;11(10):e166-96. doi: 10.1016/j.hrthm.2014.07.024. Epub 2014 Aug 30.
3
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.
美国心力衰竭学会/美国心脏病学会/美国心脏协会关于在临床试验中未纳入或代表性不足的患者中使用植入式心脏复律除颤器治疗的专家共识声明
Circulation. 2014 Jul 1;130(1):94-125. doi: 10.1161/CIR.0000000000000056. Epub 2014 May 9.
4
Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.使用可穿戴式心脏复律除颤器移除植入式心脏复律除颤器(ICD)后预防门诊患者心源性猝死
Pacing Clin Electrophysiol. 2014 May;37(5):562-8. doi: 10.1111/pace.12319. Epub 2013 Dec 3.
5
Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.穿戴式心脏除颤器在心肌梗死后早期被认为高危患者中的应用。
J Am Coll Cardiol. 2013 Nov 19;62(21):2000-2007. doi: 10.1016/j.jacc.2013.05.086. Epub 2013 Jul 31.
6
Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator.左心室功能障碍患者冠状动脉血运重建术后的早期死亡率风险及可穿戴式除颤器的潜在作用。
Circ Arrhythm Electrophysiol. 2013 Feb;6(1):117-28. doi: 10.1161/CIRCEP.112.973552. Epub 2012 Dec 28.
7
Reduction in inappropriate therapy and mortality through ICD programming.通过 ICD 编程减少不适当的治疗和死亡率。
N Engl J Med. 2012 Dec 13;367(24):2275-83. doi: 10.1056/NEJMoa1211107. Epub 2012 Nov 6.
8
Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy.晚期钆增强在肥厚型心肌病临床结局中的预测价值。
JACC Cardiovasc Imaging. 2012 Apr;5(4):370-7. doi: 10.1016/j.jcmg.2011.11.021.
9
Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery.经活检证实的病毒性心肌炎的长期随访:死亡率和不完全恢复的预测因素。
J Am Coll Cardiol. 2012 May 1;59(18):1604-15. doi: 10.1016/j.jacc.2012.01.007. Epub 2012 Feb 22.
10
Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival.可穿戴式除颤器的综合国家经验:事件发生率、依从性和生存率。
J Am Coll Cardiol. 2010 Jul 13;56(3):194-203. doi: 10.1016/j.jacc.2010.04.016.